Butylated hydroxytoluene (BHT) Pellets Manufacturer in Maharashtra, India

Pharmaceutical Grade Butylated hydroxytoluene (BHT) Pellets – Sustained Release and Multiparticulate Formulation

Butylated hydroxytoluene (BHT) Pellets Manufacturer and Bulk Supplier in Maharashtra, India – Swapnroop Pharma

Product Specifications

Product Name: Butylated hydroxytoluene (BHT) Pellets
CAS Number: 37025-55-1
Category: Pharmaceutical Pellets
Grade: Carbetocin IP / BP / EP / USP
Appearance: White to off-white crystalline powder
Standards: IP / BP / EP / USP compliant

Detailed Specifications

ParameterSpecification
AppearanceWhite to off-white crystalline powder
IdentificationIR & HPLC compliant
Assay (HPLC)98.0% – 102.0%
Loss on DryingNMT 1.0%
Residue on IgnitionNMT 0.2%
Heavy MetalsNMT 10 ppm
pH (1% Solution)2.0 – 4.0
Individual Impurity≤ 0.5%
Total Impurities≤ 1.5%

Butylated hydroxytoluene (BHT) Pellets (CAS No: 37025-55-1)

Pharmaceutical-Grade Butylated hydroxytoluene (BHT) Pellets for Modified-Release and Multi-Unit Dosage Forms

Butylated hydroxytoluene (BHT) Pellets (CAS 37025-55-1) pellets are spherical or near-spherical multi-unit pharmaceutical dosage forms manufactured by extrusion-spheronisation or rotary granulation technology. Butylated hydroxytoluene (BHT) pellets enable precise dose uniformity, flexible drug loading, and controlled release coating applications, making them ideal for modified-release capsule formulations and multi-unit pellet systems (MUPS).

Quality specifications for Butylated hydroxytoluene (BHT) pellets include sphericity (aspect ratio <1.2), friability (<1%), particle size distribution (typically 500–1400 µm for capsule fill applications), and drug content uniformity per pharmacopeial dosage form specifications. Surface smoothness and low dust content are critical for film coating adhesion in extended-release pellet formulations.

Swapnroop Drugs and Pharmaceuticals manufactures Butylated hydroxytoluene (BHT) Pellets at our WHO-GMP Aurangabad facility using validated pelletisation technology with consistent sphericity and particle size control. Our pellet manufacturing supports modified-release capsule programs, MUPS tablet development, and speciality drug delivery programs for domestic and export markets.

Key Features

  • Spherical pellets with high sphericity (aspect ratio <1.2) for uniform coating
  • Particle size distribution D10/D50/D90 controlled within specification for capsule fill
  • Low friability (<1%) for robust pellet handling and film coating processes
  • Drug content uniformity per USP <905> dosage unit sampling requirements

Applications

  • Butylated hydroxytoluene (BHT) pellets for modified-release (ER/SR) capsule formulations
  • Multi-unit pellet system (MUPS) tablet manufacturing
  • Film-coated enteric-release pellet dosage form development
  • Paediatric dose-flexible capsule fill applications

Why Choose Swapnroop for Butylated hydroxytoluene (BHT)?

  • Extrusion-spheronisation technology with validated process parameters
  • WHO-GMP facility with dedicated pelletisation equipment and clean room fill
  • Consistent sphericity and PSD data provided with each commercial batch
  • Flexible batch sizes from R&D scale to commercial production for pellet programs

Packaging & Supply

Butylated hydroxytoluene (BHT) Pellets pellets are supplied in food-grade polyethylene bags (5 kg, 10 kg) inside fiber drums with desiccant to protect against moisture-induced dissolution and caking. Anti-static inner bags used for dust-sensitive pellet handling.

Get Bulk Quote

Frequently Asked Questions about Butylated hydroxytoluene (BHT) Pellets

What is the CAS number for Butylated hydroxytoluene (BHT) Pellets?

The CAS number for Butylated hydroxytoluene (BHT) is 37025-55-1. Butylated hydroxytoluene (BHT) Pellets are multiparticulate pharmaceutical pellets manufactured for modified-release capsule and tablet formulations.

What drug release profiles are available for Butylated hydroxytoluene (BHT) Pellets?

Butylated hydroxytoluene (BHT) Pellets are available in immediate-release (IR), sustained-release (SR), and enteric-coated (EC) release profiles. Dissolution data per target profile is provided with every batch.

What size are Butylated hydroxytoluene (BHT) Pellets and how is uniformity measured?

Butylated hydroxytoluene (BHT) Pellets are manufactured in the 0.5–1.5 mm size range with tight size distribution verified by sieve analysis. Drug content uniformity (95–105% of label claim) is tested per USP/BP specifications.

What is the MOQ for Butylated hydroxytoluene (BHT) Pellets?

MOQ for Butylated hydroxytoluene (BHT) Pellets is 1 kg for formulation development and 5–10 kg for commercial programs. Contact us for volume pricing and custom dissolution profile requirements.

Are Butylated hydroxytoluene (BHT) Pellets suitable for hard gelatin capsule filling?

Yes, Butylated hydroxytoluene (BHT) Pellets are designed for hard gelatin (HPMC) capsule filling and MUPS tablet compression. Pellet size distribution, bulk density, and flow properties are optimised for automated capsule filling equipment.

Butylated hydroxytoluene (BHT) Pellets Bulk Supplier in Aurangabad, Maharashtra, India

Swapnroop Drugs and Pharmaceuticals is a trusted Butylated hydroxytoluene (BHT) Pellets manufacturer and bulk supplier in Aurangabad, Maharashtra, serving pharmaceutical formulation companies across India and 25+ international markets. Our WHO-GMP certified facility provides consistent Butylated hydroxytoluene (BHT) Pellets supply with full pharmacopeial compliance, competitive pricing, and complete regulatory documentation for domestic and export programs.

Butylated hydroxytoluene (BHT) Pellets Exporter from India – Regulatory Filing Support

As a Butylated hydroxytoluene (BHT) Pellets exporter from Maharashtra, India, Swapnroop supports pharmaceutical companies worldwide with DMF-grade documentation, Certificate of Analysis, MSDS, impurity profiles, and regulatory filing assistance for USFDA, EMA, and CDSCO submissions. Contact us for Butylated hydroxytoluene (BHT) Pellets pricing, samples, and sourcing support.